Skip to main content
Home

Breadcrumb

  1. Home
  2. Consultancy

Consultancy

Medicilon logo
9 December 2024

Medicilon large animal models such as non-human primates, dogs, rabbits, and miniature pigs have shown unique advantages and value in key areas of drug development

With the advent of the era of precision medicine and the deepening understanding of disease mechanisms, large animal models such as non-human primates, dogs, rabbits, and miniature pigs have shown unique advantages and value in key areas of drug development. ...

webinar on Tuesday, 10 December 2024, from 1:00 PM to 2:30 PM UK Time to help businesses prepare for the General Product Safety Regulation (GPSR) deadline on 13 December 2024.
2 December 2024

Navigating the EU’s General Product Safety Regulations (GPSR)

Webinar on Tuesday, 10 December 2024, from 1:00 PM to 2:30 PM UK Time to help businesses prepare for the General Product Safety Regulation (GPSR) deadline on 13 December 2024. ...

Syplex advert
5 December 2024

New local service aims to optimise costs for Cambridge businesses

Reducing Overspend on Microsoft Azure: Cambridge Network Member Exclusive: Free Session of Azure Advice Service during Dec-Jan ...

Analytics for clinical development strategy: Integrated optimization of an oncology program
15 November 2024

Analytics for clinical development strategy: Integrated optimization of an oncology program

Achieving a return on invested capital (ROIC) that exceeds the cost of capital remains a challenge for pharmaceutical R&D. To make progress, there needs to be consistent and rigorous modeling of the clinical and commercial determinants of ROIC. In the second of three articles, CRA’...

CMS’ Alzheimer’s NCD: Outlier or harbinger of increased scrutiny?
15 November 2024

CMS’ Alzheimer’s NCD: Outlier or harbinger of increased scrutiny?

Aduhelm was the first FDA-approved disease-modifying treatment for Alzheimer’s, sparking debate among providers, regulators, and patients. Aduhelm received a controversial accelerated approval from the FDA in June 2021, a decision that balanced the lack of consensuses among the scientif...

Analytics for clinical development strategy: A unified approach to optimizing return on investment in R&D
5 November 2024

Analytics for clinical development strategy: A unified approach to optimizing return on investment in R&D

Despite the rapid scientific advances with new targets, modalities, and biomarkers, the return on invested capital (ROIC) in novel therapeutics remains low. The problem stems from the large investment needed, high risks of failure, and long timelines until revenues can be realized. This...

Infertility - A public health concern
4 November 2024

Infertility - A public health concern

The World Health Organization (WHO) estimates that one out of six people globally are impacted by the inability to conceive a child. Over the last decade, countries around the world have seen a decline in total fertility rates, most notably in economically developed countries withi...

chris-dunn
20 November 2024

Chris Dunn shortlisted as a Top UK Business Adviser

Chris Dunn has been shortlisted for the UK’s Top Business Advisers Awards. Chris who delivers consulting, coaching, and mentoring services to help entrepreneurs grow their business was picked from hundreds of advisers from around the UK for his outstanding work in business development. ...

The EpiCentre, Haverhill
20 November 2024

The EpiCentre is working with Microsoft to support innovative early-stage businesses

Oxford Innovation Space that manages The EpiCentre at Haverhill and Microsoft have announced that they are working together to support the growth of innovative early-stage businesses. ...

25 August 2026

Internationalising MedTech Innovation

This session will provide a comprehensive pathway for EU-based MedTech innovators, covering market analysis, planning, compliance, and more. Each topic has been carefully selected to ensure you leave with actionable insights and a clear roadmap for entering and thriving in these new mar...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 50
  • Page 51
  • Current page 52
  • Page 53
  • Page 54
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS